GlassScriptPhysician profile
Assaf Berger
NPI 1477226587
$50,413.43
in general payments reported to CMS, 2019-2025
13 companies · $4,623 in 2025
The $4,623 reported for 2025 was more than what 80% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $43K · 2023: $1,577 · 2024: $1,274 · 2025: $4,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,934 · Travel and Lodging: $3,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,933.56 |
| Travel and Lodging | $3,540.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24,784.19 | 2022-2025 | Proclaim, Infinity, Octrode |
| Medtronic, INC. | $22,563.49 | 2022-2025 | Cd Horizon Spinal System, Mazor X System, Percept PC Brainsense |
| Boston Scientific Corporation | $787.22 | 2022-2025 | General - Dbs, Vercise |
| Nevro Corp. | $724.87 | 2023-2024 | Senza |
| Nuvasive, INC. | $248.25 | 2023 | Xlif, Tlif, Reline |
| Insightec,INC | $226.89 | 2022-2023 | Exablate |
| Globus Medical, INC. | $225.64 | 2025 | Vyrsa Fix, Omnia, Senza |
| Saluda Medical Americas, INC. | $202.33 | 2024-2025 | Evoke |
| Clearpoint Neuro, INC. | $191.26 | 2023-2024 | Clearpoint |
| Imperative Care, INC | $161.03 | 2024 | Zoom 88-T Large Distal Platform |
| Elekta, INC. | $145.47 | 2025 | Leksell Gamma Knife Icon |
| Nalu Medical, INC. | $127.04 | 2025 | Nalu Neurostimulation System |
| Mml US, INC. | $25.75 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Assaf Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.